TBC1D16 and cancer: In addition, the direction of methylation changes in EBF3 and TBC1D16 was not necessarily conserved across different cancer types, since endometrial cancer and prostate cancer in our data showed opposite patterns of methylation changes in EBF3 gene body and promoter regions compared to melanoma and colorectal cancer.